NSC-733972

N/A

Report date: 2026/05/06 20:02:28

Base Information

Drug NameNSC-733972
Drug Alias NameM032-H SV-1M-032NSC-733972
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionInterleukin-12 inhibitors
TargetsInterleukin-12
Therapy Area/IndicationsGliosarcomaGlioblastomaAstrocytoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Alabama At Birmingham
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Texas MD Anderson Cancer CenterUniversity Of Alabama At Birmingham
Inactive CompaniesN/A
Active IndicationsGliosarcomaGlioblastomaAstrocytoma +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A